In this issue:
SCT for light chain amyloidosis: decrease in early mortality
Eculizumab for PNH, and QOL
Age-adjusted D-dimer cutoff improves VTE diagnosis
Ibrutinib in treatment-naïve and relapsed/refractory CLL
Toxicities and outcomes with ibrutinib for CLL in the US
Fungal infections associated with ibrutinib
Plerixafor for haematopoietic stem cell mobilisation in sickle cell disease
Plerixafor for mobilising CD34+ haematopoietic progenitor cells in sickle cell disease
JAK2/CALR mutation subtype in Japanese patients with myeloproliferative neoplasms
Please login below to download this issue (PDF)